Performance of Immunotyping vs. Immunofixation for the Detection of Monoclonal Gammopathies

Webinar
Sep. 22, 2021

Educational Webinar with Katie Thoren, PhD, Memorial Sloan Kettering Cancer Center

Sebia and Metafora biosystems form strategic partnership to develop advanced in vitro diagnostics

Press release
Sep. 16, 2021

Sebia to acquire a minority stake in Metafora biosystems.

Multiple Myeloma clinical cases at diagnosis and monitoring according to latest IMWG recommendations

Webinar
Aug. 11, 2021

Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD

Experience and recommendations of a Major Cancer Center to use HYDRASHIFT daratumumab

Publication
Aug. 09, 2021

Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.

Our complete product range

Instruments

From the lowest to the highest volumes, with standalone instruments, workcell configurations or directly integrated into lab track automation, Sebia will provide the right solution for each laboratory.

See all our instruments

Tests

From multiple myeloma to metabolic disorders, hemoglobinopathies and genetic diseases, Sebia’s portfolio is designed to address clinical needs and improve laboratory efficiency and safety.

See all our tests

Our solutions tailored for your needs

Software

The networked expert companion of all Sebia instruments.

Learn more

Sebia Lean Service

With a modular and scalable offer, Sebia Lean Service is designed to enhance the laboratory performance with customized product and management solutions.

Learn more

Sebia Academy

We aim to educate and share scientific and medical educational information with our customers all around the world.

Learn more

Sebia Service

We offer daily assistance for technical and scientific matters.

Learn more

Our key figures

+16 000
installed instruments worldwide
+120
countries covered
+700
employees worldwide
0
Sebia Capillary Electrophoresis Protein tests performed in the world from Jan 1st, 2021

Create your free account MySebia

Customize your viewing experience
Get access to exclusive events near you
Bookmark and keep all your resources in one place
Subscribe to specific newsletters and content